|
gptkbp:instanceOf
|
vaccine
live attenuated bacterial strain
|
|
gptkbp:administeredBy
|
intradermal injection
|
|
gptkbp:alsoKnownAs
|
gptkb:BCG_vaccine
|
|
gptkbp:ATCCode
|
gptkb:J07AN01
|
|
gptkbp:contains
|
gptkb:attenuated_Mycobacterium_bovis
|
|
gptkbp:contraindication
|
pregnancy
immunocompromised patients
|
|
gptkbp:developedBy
|
gptkb:Camille_Guérin
gptkb:Albert_Calmette
|
|
gptkbp:effect
|
variable by region
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Bacillus Calmette-Guérin
|
|
gptkbp:includedIn
|
childhood immunization schedules in many countries
|
|
gptkbp:introducedIn
|
1921
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:namedAfter
|
gptkb:Camille_Guérin
gptkb:Albert_Calmette
|
|
gptkbp:producedBy
|
various manufacturers worldwide
|
|
gptkbp:protectionDuration
|
10–20 years
|
|
gptkbp:routeOfAdministration
|
intradermal
|
|
gptkbp:sideEffect
|
lymphadenitis
ulcer at injection site
|
|
gptkbp:storage
|
2–8°C
|
|
gptkbp:usedFor
|
bladder cancer treatment
tuberculosis prevention
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:bfsParent
|
gptkb:BCG
|
|
gptkbp:bfsLayer
|
6
|